NIM
MRNA icon

NEOS Investment Management’s Moderna MRNA Stock Holding History

NEOS Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.92M Buy
56,031
+5,811
+12% +$301K 0.01% 409
2026
Q1 		$2.55M Buy
50,220
+4,125
+9% +$192K 0.01% 459
2025
Q4 		$1.36M Buy
46,095
+7,433
+19% +$202K 0.01% 516
2025
Q3 		$999K Buy
38,662
+13,258
+52% +$370K 0.01% 522
2025
Q2 		$701K Buy
25,404
+5,355
+27% +$141K 0.01% 504
2025
Q1 		$568K Sell
20,049
-5,716
-22% -$203K 0.01% 508
2024
Q4 		$1.07M Sell
25,765
-17,143
-40% -$819K 0.03% 398
2024
Q3 		$2.87M Buy
42,908
+6,509
+18% +$598K 0.09% 211
2024
Q2 		$4.32M Buy
36,399
+13,258
+57% +$1.68M 0.18% 108
2024
Q1 		$2.47M Buy
23,141
+2,980
+15% +$300K 0.15% 127
2023
Q4 		$2.01M Buy
20,161
+4,049
+25% +$341K 0.19% 107
2023
Q3 		$1.66M Buy
+16,112
New +$1.8M 0.21% 100

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

NEOS Investment Management's MRNA Position: Q2 2026 in Review

NEOS Investment Management increased its Moderna (MRNA) stake by 12% in Q2 2026, buying an estimated $301K and bringing the position to 56,031 shares worth $3.92M. The position accounts for 0.01% of the portfolio, ranked #409.

NEOS Investment Management first reported a position in MRNA in Q3 2023 and has held it in 12 quarters since. The position peaked at $4.32M in Q2 2024. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • NEOS Investment Management held 56,031 shares of Moderna worth $3.92M as of Q2 2026.
  • NEOS Investment Management bought 5,811 Moderna shares in Q2 2026, an estimated $301K.
  • Moderna made up 0.01% of NEOS Investment Management's portfolio in Q2 2026, its #409 holding.
  • NEOS Investment Management first reported a position in Moderna in Q3 2023 and has held it in 12 quarters since.
  • NEOS Investment Management's Moderna position peaked at $4.32M in Q2 2024.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on NEOS Investment Management's 13F filing for Q2 2026, filed 11 Aug 2026.